Amy O'Shea
Director/Board Member at GENSOURCE POTASH CORPORATION
Net worth: 47 139 $ as of 2024-06-29
Network origin in Amy O'Shea first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering, Inc. (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.
172
| Private Company | Investment Managers | 172 |
| Public Company | Chemicals: Agricultural | 15 | |
Invaio Sciences, Inc.
 Invaio Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Invaio Sciences, Inc. operates as multi-platform technology company. The firm develops multi-platform technology company that unlocks the potential of planet's interdependent natural systems to solve pressing agriculture, nutrition and environmental challenges. The company was founded in 2018 and is headquartered in Cambridge, MA.
11
| Holding Company | Miscellaneous Commercial Services | 11 |
| Public Company | Chemicals: Agricultural | 9 | |
Vive Crop Protection, Inc.
 Vive Crop Protection, Inc. Chemicals: AgriculturalProcess Industries Vive Crop Protection, Inc. develops crop protection products. The firm specializes in crop protection, delivery, agronomy, formulations chemistry, polymer chemistry, chemical engineering, industrial manufacturing development and patents. Its products include AZteroid, Bifender and Fenstro. The company was founded in 2006 and is headquartered in Toronto, Canada.
8
| Holding Company | Chemicals: Agricultural | 8 |
Integrated Agriculture Systems, Inc.
 Integrated Agriculture Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Integrated Agriculture Systems, Inc. engages technological development of reducing environmental impact and increasing crops. It offers consulting and custom solutions design, aquaponic systems, stem ecosystems, research and development, and training and support services. It serves the restaurant, hospitality, farming, distribution, elementary, secondary, and collegiate sector. The company was founded by Edgar C. Harrell and is headquartered in Newark, CA.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Amy O'Shea via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Director/Board Member Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Founder Founder Director/Board Member Founder Chief Executive Officer President | |
| AXCA HEALPAR | Biotechnology | Founder Director/Board Member Director of Finance/CFO Founder Director/Board Member Chairman | |
Montai Health, Inc.
 Montai Health, Inc. Packaged SoftwareTechnology Services Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation. | Packaged Software | Founder Director/Board Member Director/Board Member Founder Chief Operating Officer Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Founder Chief Executive Officer Chairman President | |
CiBO Technologies, Inc.
 CiBO Technologies, Inc. Packaged SoftwareTechnology Services CiBO Technologies, Inc. is a science-driven software company which engage sin the modelling and simulation of agricultural ecosystems. The firm offers CIBO and CIBO Plus software products. The company was founded by Ignacio Bemposta Martinez and Bruno Basso in 2015 and is headquartered in Cambridge, MA. | Packaged Software | Director/Board Member Director/Board Member Founder Chairman Director/Board Member | |
Inari Agriculture, Inc.
 Inari Agriculture, Inc. BiotechnologyHealth Technology Inari Agriculture, Inc. engages biotechnology research and development. It specializes in plant breeding technology. The company was founded by David Berry, Ignacio Martinez, George Church, and Steve Jacobsen in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Founder Founder Director/Board Member Director/Board Member | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Chairman Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Founder Director/Board Member Chairman | |
Ampersand Biomedicines
 Ampersand Biomedicines BiotechnologyHealth Technology Ampersand Biomedicines is an American company that designs programmable medicines that work precisely where needed in the body and nowhere else. The company's computationally powered platform identifies ideal addresses for drug localization and informs the design of and-body™ therapeutics that have the optimal therapeutic effect. The result is smarter biologic medicines that target the site of disease without affecting healthy tissue or cells. Ampersand is enabling potent mechanisms to treat disease by creating and programming therapeutics that are more efficacious, without compromising on safety or tolerability. The company was founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Jason Gardner has been the CEO of the company since 2023. | Biotechnology | Founder Founder Chief Executive Officer Founder | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Founder Chief Administrative Officer Founder | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member Founder | |
| University of Saskatchewan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| New York University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member Founder | |
| BG MEDICINE, INC. | Medical Specialties | Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Profound Therapeutics
 Profound Therapeutics Pharmaceuticals: OtherHealth Technology Profound Therapeutics is a company that is focused on discovering new medicines by expanding the human proteome. The company is based in Cambridge, MA. The company uses their platform, Profoundry, to identify and validate proteins and understand their therapeutic potential. This results in a growing database of novel proteins and their roles in health and disease. The company was founded in 2020 by Avak Kahvejian, who has been the CEO since then. | Pharmaceuticals: Other | Chairman Chief Executive Officer President | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Inzen Therapeutics, Inc.
 Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | Director/Board Member Director/Board Member President | |
| MODERNA, INC. | Biotechnology | Director/Board Member Founder Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder Chairman | |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member Founder | |
| University of California | College/University | Undergraduate Degree Undergraduate Degree | |
Affinnova, Inc.
 Affinnova, Inc. Information Technology ServicesTechnology Services Affinnova, Inc. is a global marketing technology, which provides sales solutions for large and mid-sized enterprises. The company was founded by Kamal M. Malek in 2000 and is headquartered in New York, NY. | Information Technology Services | Founder Director of Finance/CFO | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Founder | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Doctorate Degree | |
LS Dissolution, Inc.
 LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Chemicals: Major Diversified | Founder Founder | |
Alltrna
 Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius. | Biotechnology | Chairman Chief Executive Officer | |
Harbinger Health
 Harbinger Health Information Technology ServicesTechnology Services Harbinger Health, Inc. is a company based in Cambridge, MA. Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test. Harbinger envisions a future where cancer could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems, and societies. The company fundamentally transforms cancer care for everyone. The company was founded in 2020 by Alexander Meissner, Sidney Farber, Zachary Smith, Franziska Michor. The CEO is Stephen Hahn. | Information Technology Services | Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree |
Statistics
International
| United States | 48 |
| Canada | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 14 |
| Technology Services | 5 |
| Commercial Services | 4 |
| Process Industries | 3 |
Operational
| Director/Board Member | 233 |
| Corporate Officer/Principal | 110 |
| Founder | 110 |
| Private Equity Investor | 72 |
| Undergraduate Degree | 69 |
Most connected contacts
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| George Church | 45 |
| Margo Georgiadis | 34 |
| Ed Kania | 31 |
| Michael Rosenblatt | 31 |
| Theo Melas-Kyriazi | 26 |
| Ignacio Martinez | 21 |
| Geoffrey von Maltzahn | 15 |
| Diego Miralles | 14 |
| Robert Berendes | 13 |
| Jonathan Ian Schwartz | 13 |
| Rupert Vessey | 13 |
| Avak Kahvejian | 13 |
| Jeffrey Moore | 12 |
| Gary Pisano | 11 |
- Stock Market
- Insiders
- Amy O'Shea
- Company connections
